CovalX
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
 | |
| Company type | Private |
|---|---|
| Industry | Life Sciences |
| Founded | 2005 |
| Founder | Ryan Wenzel Alexis Nazabal Urs Matter |
| Headquarters | , |
Area served | Worldwide |
| Products | CRO Business |
| Services | MS Analysis |
| Website | https://covalx.com/ |
CovalX AG is a Zürich, Switzerland-based biotechnology research company that develops analytical solutions for the characterization of biotherapeutics for the life science industry.
Origins[edit]
A spin-off of the Swiss Federal Institute of Technology (ETHZ), CovalX was founded by Ryan Wenzel, Alexis Nazabal, and Urs Matter in 2005 as CovalX GmbH and was converted in January 2007 to AG status to allow additional investors into the company.
In 2011, CovalX founded a US subsidiary called CovalX Instruments Incorporated located in the Boston area. They began manufacturing and testing of their equipment as well as sales and support for their hardware products.
After establishing its first laboratory in Zürich, CovalX founded laboratories in Boston (2011) and Bordeaux (2017).
One focus of CovalX was measuring intact protein complexes by MALDI mass spectrometry.[1] They distribute chemical kits, high mass detection hardware and analysis software.
From 2009, CovalX began focusing on analytical service measurements through its growing CRO laboratories in Switzerland and France
Awards[edit]
In April 2006, CovalX received the CTI Start-up Label from the Swiss Confederation's Commission for Technology and Innovation.[2]
References[edit]
- ^ "Shimadzu and CovalX Launch the AXIMA MegaTOF™ for Ultrahigh-Mass Applications". Technology Networks. 16 June 2010. Retrieved 30 June 2018.
- ^ List of CTI approved Companies Archived 2011-07-06 at archive.today ctistartup.ch